Key facts
- This page summarizes Sofinnova Venture Partners X, L.P.'s Form 4 filing for Vera Therapeutics, Inc. (VERA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 08 Feb 2023, 17:29.
Sofinnova Venture Partners X, L.P. - 06 Feb 2023 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- VERA
- Reported as of
- 06 Feb 2023
- Net transaction value
- +$1,999,998
- SEC form
- 4
- Accepted by SEC
- 08 Feb 2023, 17:29:55 UTC
- Prior SEC filing
- 15 Aug 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nathalie Auber, as attorney-in-fact for Sofinnova Venture Partners X, L.P.
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Sofinnova Venture Partners X, L.P. filed Form 4 for Vera Therapeutics, Inc. (VERA) on 08 Feb 2023.
Change
- Previous filing in this sequence was filed on 15 Aug 2022.
- Current net transaction value: +$1,999,998.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VERA
transaction
Class A Common Stock
Purchase
- Transaction value
- $1,999,998
- Shares
- +285,714
- Change %
- +9%
- Price
- $7.00
- Shares after
- 3,467,156
- Date
- 06 Feb 2023
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The shares are held directly by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.P. ("SM X LP") is the general partner of SVP X and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by SVP X. Sofinnova Management X-A, L.L.C. ("SM X LLC") is the general partner of SVP X LP and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by SVP X. James I. Healy and Maha Katabi are the managing members of SM X LLC and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by SVP X. Each of the Reporting Persons disclaims beneficial ownership of such securities, except to the extent of his, her or its proportionate pecuniary interest therein.